目的分析线粒体融合蛋白2(MFN2)基因在中国人腓骨肌萎缩症的突变情况,建立快速、有效和经济的基因诊断方法。方法应用变性高效液相色谱(DHPLC)结合DNA直接测序的方法,对9个常染色体显性遗传的CMT2先证者和26个散发CMT2病例共35例患者进行MFN2皋因编码区17个外显子及其侧翼区的突变检测。结果在35例腓骨肌萎缩症患者中共检测到3种MFN2基因序列变异:c.281G→A,c.395G→A和c.408A→T,其中c.395G→A(C132T)为首次报道的致病突变,c.281G→A(R94Q)为已知致病热点突变,c.408A→T(V136V)为单核苷酸多态。DHPLC突变检测的敏感性和特异性为100%。结论首次在国内应用DHPLC结合DNA白直接测序埘MFN2基因进行突变检测,发现2个致病突变和1个单核苷酸多态。DHPLC结合DNA直接测序法可准确有效地用于大规模MFN2基冈突变筛查。
Objective To analyze MFN2 gene mutation in Chinese patients Charcot-Marie-Tooth disease (CMT) and to establish a quick and effective diagnostic method. Methods Through denaturing high-performance liquid chromatography (DHPLC) combined with DNA sequencing, MFN2 gene mutation analysis was carried out in 35 Chinese CMT2 patients including 9 probands of CMT2 pedigree and 26 sporadic CMT2 patients. Results The investigators found three abnormal sequence variations in MFN2 gene:c. 281G→A, c. 395G→A and c. 408A→T. c. 395G→A (C132T) was a novel causative missense mutation firstly reported while c. 281G→A (R94Q) a hotspot mutation and c. 408A→T(V136V) a single nucleotide polymorphism (SNP). The accuracy and specificity of DHPLC detection reached up to 100%. Conclusion Through DHPLC combined with DNA sequencing, MFN2 mutations are detected in Chinese CMT2 patients. There are two causative missense mutations: c. 395G→A (C132T) and c. 281G→A (R94Q) and one SNP c. 408A→T (V136V). Such a method is an effective and economic diagnostic screening tool of MFN2 gene in CMT patients on a large scale.